Magnesium L-Threonate for Health & Longevity - Quick Reference Sheet

Magnesium L-Threonate for Health & Longevity

Created on 10/21/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5.5 – Audit

Magnesium L-threonate is a dietary supplement form of magnesium built to reach the brain more easily, promoted mainly for memory, sleep and long-term brain health. A few small, short, mostly company-funded studies show modest gains in thinking and memory scores; sleep results are weaker and mood results mostly flat. Risks look small, mainly magnesium building up with reduced kidney function. Its added value over ordinary magnesium remains uncertain. (Full Review)

Protocol

Standard trial dose
2 g/day of Magtein
About 145 mg elemental magnesium; 1 g in the morning and 1 g two hours before bed, for 6 weeks
Developer's weight-based dose
About 25 mg/kg/day
1.5 g/day for 50–70 kg or 2 g/day for 70–100 kg, for 12 weeks
Lower sleep-focused dose
1 g/day
About 75 mg magnesium, taken 2 hours before bed, for 21 days
Time to effect
Cognitive performance
6–12 weeks
Cognitive changes were measured at 6–12 weeks
Relief of opioid-induced constipation
From day 7
Constipation scores lower than placebo from day 7 onward
Sleep quality
7–14 days
Some sleep-related and alertness measures separated from placebo

Benefits

Contraindications
  • Severe kidney impairment, such as serum creatinine of 2.0 mg/dL or higher
  • Pregnant or breastfeeding women
  • Children and adolescents
  • Myasthenia gravis or heart conduction block (theoretical)
Key Interactions
  • Fluoroquinolone antibiotics (ciprofloxacin, levofloxacin): Caution
  • Integrase inhibitors (drugs against HIV, the human immunodeficiency virus) (dolutegravir, bictegravir): Caution
  • Tetracycline antibiotics (doxycycline, minocycline): Caution
  • Bisphosphonates (bone-loss drugs) (alendronate, risedronate): Caution
  • Gabapentin (a nerve-pain and seizure drug): Caution
  • Thyroid hormone (levothyroxine): Monitor
  • Proton pump inhibitors (acid-reducing drugs) (omeprazole, pantoprazole): Monitor
  • Loop or thiazide diuretics (fluid-removing drugs) (furosemide, hydrochlorothiazide): Monitor (theoretical)
  • Potassium-sparing diuretics (fluid-removing drugs that retain potassium) (amiloride, spironolactone): Monitor (theoretical)
  • Antihypertensives (blood-pressure drugs), including calcium channel blockers (amlodipine, nifedipine): Monitor (theoretical)
  • Magnesium-containing antacids and laxatives (magnesium hydroxide, magnesium citrate): Caution (theoretical)
  • Other magnesium supplements (glycinate, citrate): Caution (theoretical)
  • Calcium, iron and zinc supplements: Monitor (theoretical)
  • Sleep-supporting supplements (L-theanine, melatonin): Monitor (theoretical)
  • Blood-pressure-lowering supplements (potassium, fish oil): Monitor (theoretical)
  • Alcohol: Monitor (theoretical)
  • NMDA-blocking drugs (memantine, ketamine): Monitor (theoretical)

Risk & Side Effects

  • High:
  • Medium:
  • Low: Gastrointestinal upset; hypermagnesemia with impaired kidney function
  • Speculative: Unknown long-term effects; additive lowering of heart rate and blood pressure

Monitoring

Marker Target Why
Serum magnesium ≥0.85 mmol/L Safety check: flags excess, or deficiency that changes use
Red-blood-cell magnesium About 4.0–6.8 mg/dL, varying by laboratory Safety check: low values change use
Serum creatinine and eGFR Creatinine about 0.6–1.3 mg/dL; eGFR: track change from own baseline Safety check: kidneys clear magnesium; decline stops or changes use

Cadence: Baseline before starting; check at 6 weeks, full review at 12 weeks, then every 6–12 months. Kidney function and serum magnesium at 12 weeks, then annually; sooner with kidney disease, interacting drugs or symptoms such as weakness.

Qualitative Assessment

  • Sleep quality: time to fall asleep, night wakings, morning refreshment, and wearable deep-sleep estimates
  • Cognitive clarity: performance on the same memory or reaction-time test repeated under similar conditions
  • Daytime energy, alertness and mood
  • Gastrointestinal tolerance: stool consistency and abdominal comfort
  • Sleeping heart rate and heart rate variability from a wearable, if available